• Contact Us
  • About
  • Advertise
  • Careers
Kashmir Dot Com
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
Kashmir Dot Com
No Result
View All Result
Home Health

AstraZeneca Acknowledges Rare Blood Clot Side Effects of Covid Vaccine: Here’s What We Know

Kashmir Dot Com by Kashmir Dot Com
April 30, 2024
in Health, World
0
AstraZeneca Acknowledges Rare Blood Clot Side Effects of Covid Vaccine: Here’s What We Know
0
SHARES
151
VIEWS
Share on Facebook

New Delhi, April 30: Benefits of the Covid-19 vaccine far outweigh the risks of extremely rare potential side effects, pharma giant AstraZeneca said on Tuesday.

The company’s response, in a statement to IANS, comes amidst furore over the company admitting in UK court documents that its vaccine against Covid-19, developed in partnership with Oxford University, can raise the risk of a rare and serious blood clot.

“From the body of evidence in clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continuously been shown to have an acceptable safety profile,” the statement said.

“Regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects,” it added.

The Oxford-AstraZeneca Covid vaccine, sold as Covishield in India and Vaxzevria in Europe is a viral vector vaccine developed using the modified chimpanzee adenovirus ChAdOx1.

In a legal document submitted to the UK High Court, in February, “AstraZeneca accepted that its Covid vaccine ‘can, in very rare cases, cause TTS’”, the Telegraph reported.

Thrombosis Thrombocytopenia Syndrome (TTS) is a disorder that causes people to have blood clots and a low blood platelet count.

A total of 51 cases have been lodged in the UK High Court against the pharmaceutical giant over claims that its Covid vaccine caused death and serious injury. The victims and grieving relatives have sought damages, estimated to be worth up to 100 million pounds, the report said.

The company also expressed sympathy with the people who suffered loss of lives or health due to its vaccine, and asserted that “patient safety is our highest priority”.

“Our sympathy goes out to anyone who has lost loved ones or reported health problems,” AstraZeneca said.

“Patient safety is our highest priority and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines,” the company added.

Meanwhile, health experts noted that AstraZeneca’s Covid vaccine having side effects is nothing new in terms of information, and nothing new that should make us fearful.

“The furore about Covishield is quite surprising. Nothing new in terms of information and more importantly nothing in that information that should make us fearful of vaccines,” Dr. Anurag Agrawal, a pulmonologist and Dean, BioSciences and Health Research, Trivedi School of Biosciences, Ashoka University, shared in a post on X.com

Tags: AstraZeneca
Previous Post

Election Commission Reschedules Polling Dates for Anantnag-Rajouri Parliamentary Seat

Next Post

GMC Anantnag Bids Farewell to Superannuating Professors, Prof (Dr) Anjum Farhana and Prof (Dr) Latief Siddiqui

Next Post
GMC Anantnag Bids Farewell to Superannuating Professors, Prof (Dr) Anjum Farhana and Prof (Dr) Latief Siddiqui

GMC Anantnag Bids Farewell to Superannuating Professors, Prof (Dr) Anjum Farhana and Prof (Dr) Latief Siddiqui

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

LATEST NEWS

Centre Transfers Three IAS Officers from Delhi to Jammu and Kashmir

J&K SEC Shantmanu attends meeting with President at Rashtrapati Bhavan

Spl Secy Cabinet Secretariat reviews deregulation reforms with Chief Secretary Dr. Sajjan

IndiGo cancels Saudi Arabia flights till Nov 30

FDA Seals Hattrick’s Storage Area in Rajbagh Over Food Safety Violations; 69 Inspections Conducted Across J&K

JKSA Slams BGSBU VC Over Invitation to RSS Pracharak Indresh Kumar as Chief Guest, Seeks Probe

SMC Seals Unauthorised Car Washing Centre in Srinagar’s Natipora

NIT Srinagar selects three teams for National-Level Design for Bharat 2027 challenge

Article 21 means nothing but lip service if police fancy dictates preventive detention: J&K High Court

Only Handful of Foreign Terrorists Remain in J&K, UT Will Soon Be Terror-Free: LG Sinha

Facebook Twitter

About Us

Kashmir Dot Com (KDC) is J&K's premier News Agency having a vast reach of audience.

Kashmir Dot Com is a News Agency based in Srinagar, J&K that offers syndicated multimedia news feed to plethora of news-bureaus in J&K and beyond. We also provide a range of facilities from foreign and domestic channels to package their reports in Jammu and Kashmir. We cover almost all areas of interest in J&K to viewers including news, entertainment, and life styles, bussiness, sports, human-interest features and social and developmental issues.

KDC can well and truly take pride in the legacy of it's work, and in it's contribution towards the building of a free and fair Press in Jammu and Kashmir.

Category

  • Business
  • Entertainment
  • Health
  • JAMMU
  • Kashmir
  • Lead
  • National
  • Opinion
  • Politics
  • Science
  • Sports
  • Tech
  • Uncategorized
  • World

Company Info

  • Contact Us
  • About
  • Advertise
  • Careers

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

error: Content is protected !!
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.